# Bioreliance Corporation, Rockville, MD – FDA Inspections

Source: https://www.keypedia.com/companies/bioreliance-corporation/08d3dc20-6c7e-4f04-bb98-bbc868e70000

> Inspection records and compliance data for Bioreliance Corporation in Rockville, Maryland. 12 FDA inspections on record, 4 Form 483s, last inspected January 29, 2026.

---

## Details

- Name: Bioreliance Corporation
- FEI Number: 1122041
- Address Line 1: 14920 Broschart Rd
- City: Rockville
- State: Maryland
- Zip Code: 20850
- Country Name: United States
- Address: 14920 Broschart Rd, Rockville, Maryland 20850, United States
- Country: United States

## Related Documents

- [483 - Bioreliance Corporation - Unknown Date](https://www.keypedia.com/records/483/bioreliance-corporation/b0edcd89-77c9-4465-990a-45d7a062c755) — source: FDA, date: Invalid Date
- [483 - Bioreliance Corporation - 2026-01-29](https://www.keypedia.com/records/483/bioreliance-corporation/672a1c90-d840-45b0-bc88-e5785ab1771d) — source: FDA, date: January 29, 2026
- [FDA Inspection 1295306 - Bioreliance Corporation - 2026-01-29](https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/e199758b-3727-437f-82a7-ea444bde9780) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 29, 2026
- FDA Inspection 1295306 - Bioreliance Corporation - 2026-01-29 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 29, 2026
- [483 - Bioreliance Corporation - 2024-11-22](https://www.keypedia.com/records/483/bioreliance-corporation/0a91692f-a886-49cb-a834-736dbccf3145) — source: FDA, date: November 22, 2024
- [FDA Inspection 1254934 - Bioreliance Corporation - 2024-11-22](https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/7941bc6b-db19-4266-b05d-af8a19fbde51) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 22, 2024
- FDA Inspection 1254934 - Bioreliance Corporation - 2024-11-22 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 22, 2024
- [FDA Inspection 1215040 - Bioreliance Corporation - 2023-08-04](https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/89149f6b-0201-4f3c-9500-60de669dfba4) — classification: No Action Indicated (NAI), source: FDA, date: August 4, 2023
- [EIR - Bioreliance Corporation - 2019-08-08](https://www.keypedia.com/records/eir/bioreliance-corporation/806b06f3-c04a-4a12-81af-59e936cc50d5) — source: FDA, date: August 8, 2019
- [FDA Inspection 1099981 - Bioreliance Corporation - 2019-08-08](https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/7e151514-be3f-4b8f-ba64-e4ad411f7cc0) — source: FDA, date: August 8, 2019
- [EIR - Bioreliance Corporation - 2018-07-13](https://www.keypedia.com/records/eir/bioreliance-corporation/4b7d144e-2850-4fc9-8a87-54e30822e3c8) — source: FDA, date: July 13, 2018
- [FDA Inspection 1059115 - Bioreliance Corporation - 2018-07-13](https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/ba69306a-6c03-404f-b4e3-7b18e0e140f0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 13, 2018
- FDA Inspection 1059115 - Bioreliance Corporation - 2018-07-13 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 13, 2018
- FDA Inspection 983525 - Bioreliance Corporation - 2016-01-11 — classification: No Action Indicated (NAI), source: FDA, date: January 11, 2016
- [FDA Inspection 879780 - Bioreliance Corporation - 2014-05-14](https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/1323116a-d6ef-4b45-870f-493709f1e032) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 14, 2014
- [EIR - Bioreliance Corporation - 2008-09-29](https://www.keypedia.com/records/eir/bioreliance-corporation/9e3d8b23-44f6-4814-bc27-750fefd4cc3b) — source: FDA, date: September 29, 2008

## Related Companies

- [Eurofins PROXY Laboratories B.V.](https://www.keypedia.com/companies/eurofins-proxy-laboratories-bv/2efa7b51-ca37-4d11-aa86-bb3a7d987ca7)
- [Charles River Laboratories, Inc.](https://www.keypedia.com/companies/charles-river-laboratories-inc/3a0d2bc1-66b3-441b-9c7f-1f32a705b2ef)
- [Pharmaron Lab Services LLC](https://www.keypedia.com/companies/pharmaron-lab-services-llc/9e4d9585-b814-46c1-bbff-42a9b5abee96)
- [Associates of Cape Cod, Inc.](https://www.keypedia.com/companies/associates-of-cape-cod-inc/c3c3c25d-3eec-4ab0-826d-a9c915ae89d2)
- [WuXi AppTec, Inc.](https://www.keypedia.com/companies/wuxi-apptec-inc/5a415856-23a1-4f69-a085-cda0d9ae9ca3)
- [Eurofins Lancaster Laboratories, Inc](https://www.keypedia.com/companies/eurofins-lancaster-laboratories-inc/fdb282e8-01fc-4626-8794-1b7394ba0890)
- [North American Science Associates Inc](https://www.keypedia.com/companies/north-american-science-associates-inc/4d7ae3a6-adaf-49ae-becb-ab842da002d9)
- [PPD Development, L.P.](https://www.keypedia.com/companies/ppd-development-lp/0d495b78-4879-42fc-8887-4e0294e69720)
- [Element Materials Technology Boston - Acton Inc.](https://www.keypedia.com/companies/element-materials-technology-boston-acton-inc/24258d5a-8309-4e67-90f1-adda6124441c)
- [Charles River Laboratories Ireland Ltd.](https://www.keypedia.com/companies/charles-river-laboratories-ireland-ltd/baf99307-f916-42f8-8707-410d236f27c3)

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/philip-j-snoy/137342e5-a459-47eb-b8dd-7bb6fd923e66)
- [Barbara Breithaupt](https://www.keypedia.com/people/barbara-breithaupt/710dedb7-6108-4ece-8ce3-e31a0c734cfd)
- [investigator](https://www.keypedia.com/people/susan-m-jackson/2a4e01d1-8761-4d40-b493-69a4163473bb)
- [issuing_officer](https://www.keypedia.com/people/zhou-chen/03362438-eba1-4010-b6b1-5cccf25a824c)
- [recipient](https://www.keypedia.com/people/david-j-bruning/10f2e638-2477-48e4-b8f7-6f9c93b44d3d)
